fibrinogen/thrombin

Drug Overview

The combination of fibrinogen and thrombin forms the basis of highly specialized biological therapeutic agents used in surgery and hematology. Classified as Topical Hemostatics, these medications act as medical-grade biological glues or sealing patches. While systemic hematology drugs work from inside the bloodstream, fibrinogen/thrombin products are applied directly onto an actively bleeding wound or surgical site. They are an essential operating room tool used to control bleeding and seal tissues when traditional surgical techniques—such as suturing, stapling, or electrocautery are insufficient, impractical, or physically impossible due to fragile tissue.

• Generic Name / Active Ingredients: Fibrinogen (Human or Equine) and Thrombin (Human or Bovine)
• US Brand Names: * Liquids/Sprays: Tisseel, Evicel, Artiss, Vistaseal
  • Powders: Raplixa
  • Sponges/Patches: TachoSil, Evarrest
• Drug Class: Topical Hemostatic / Fibrin Sealant Complex
• Route of Administration: Topical (Sprayed, dripped, dusted, or applied as a physical patch)
• FDA Approval Status: Fully FDA-approved for use as an adjunct to hemostasis in surgical procedures.

What Is It and How Does It Work? (Mechanism of Action)

To understand how a fibrinogen/thrombin product works, it is helpful to look at the human body’s natural blood-clotting process (the coagulation cascade). When you are injured, your body initiates a complex chain reaction that eventually activates an enzyme called thrombin. Thrombin’s job is to convert a circulating protein called fibrinogen into long, sticky threads of fibrin. These fibrin threads weave together, capturing platelets and red blood cells to form a solid clot.

Fibrinogen/thrombin hemostatics bypass the entire bodily chain reaction and skip straight to this final, clot-forming step.

When the surgeon applies the product (whether pushing two liquid liquids through a mixing syringe, or pressing a dry powder/patch onto the wet tissue), the highly concentrated thrombin instantly meets the concentrated fibrinogen on the wound’s surface. The thrombin immediately cleaves the fibrinogen, rapidly cross-linking it to form a localized, stable fibrin clot in seconds to minutes.

A Major Clinical Advantage: Because this medication supplies its own thrombin and fibrinogen, it works independently of the patient’s own coagulation system. It will successfully form a clot even if the patient is heavily medicated with blood thinners (like heparin) or suffers from severe bleeding disorders (like hemophilia).

FDA-Approved Clinical Indications

Primary Indications

Fibrinogen/thrombin products are indicated as an adjunct to hemostasis for mild to moderate bleeding in adult and pediatric patients undergoing surgery when control of bleeding by standard surgical techniques is ineffective or impractical.

Specific approved applications often depend on the formulation:

• Cardiopulmonary & Vascular Surgery: To seal bleeding heart tissue, aortic grafts, or fragile blood vessels (often using patches like Evarrest or TachoSil).
• Hepatic (Liver) and Splenic Surgery: To stop broad surface oozing on highly vascular, sponge-like organs where stitches would simply tear the tissue.
• Neurosurgery: To seal the dura mater (the membrane protecting the brain and spinal cord) to prevent dangerous cerebrospinal fluid (CSF) leaks.
• Skin Grafting: Specialized ratios of fibrinogen and thrombin (like the brand Artiss) are used to adhere delicate skin grafts to burn wounds without staples.

Dosage and Administration Protocols

Because this is a localized surgical tool, dosing is not measured in milligrams per day. Instead, the required volume or patch size is dictated entirely by the surface area of the bleeding tissue.

Important Administration Rules:

• Topical Use ONLY: These products must never be injected directly into a blood vessel.
• Surface Preparation: For liquid sealants, the surgeon must blot the target tissue as dry as possible immediately before application so the liquid isn’t washed away. Conversely, dry patches and powders often require active bleeding or a saline moistening to activate the proteins.

Clinical Efficacy and Research Results

Clinical data consistently demonstrates that fibrinogen/thrombin hemostatics significantly reduce “time-to-hemostasis” (often stopping active bleeding within 1 to 3 minutes). In high-risk procedures like liver resections or complex cardiovascular bypass surgeries, the use of topical fibrin effectively seals microscopic capillary oozing that cannot be addressed with a needle and thread. Research confirms that utilizing these agents decreases post-operative blood loss, reduces the need for allogeneic blood transfusions, and minimizes surgical drain output.

Safety Profile and Side Effects

Strict Warnings

• Intravascular Injection Risk: If a fibrinogen/thrombin sealant is accidentally injected directly into a vein or artery, it will instantly cause a massive, fatal thromboembolism (systemic blood clot) and cardiovascular collapse.
• Pathogen Transmission: Because the active proteins are derived from pooled human or animal plasma, there is a theoretical risk of transmitting infectious agents (such as viruses or prions), despite rigorous donor screening and viral-inactivation processes.

Common side effects (>5%)

Because this is applied topically during surgery, side effects are generally related to the surgical procedure itself, but can include:

• Post-operative fever (pyrexia)
• Increased wound drainage or seroma (fluid buildup under the skin)
• Post-operative nausea

Serious adverse events

• Hypersensitivity / Anaphylaxis: Severe allergic reactions can occur. Some products utilize bovine (cow) thrombin or synthetic stabilizers, which can trigger anaphylactic shock in patients with specific animal protein allergies.
• Air/Gas Embolism: If a liquid sealant is sprayed using a pressurized gas device, holding the spray tip too close to the tissue can accidentally force gas into open blood vessels, causing a life-threatening air embolism.

Ongoing Research Area: Advanced Bioengineering and Localized Drug Delivery

Current hematological and bioengineering research is heavily focused on expanding the use of fibrinogen/thrombin matrices beyond simple surgical hemostasis. Scientists are actively investigating the use of the fibrin clot as a localized “drug delivery system.” By embedding targeted antibiotics, chemotherapy agents, or regenerative stem cells into the fibrinogen component prior to application, researchers hope the resulting clot will slowly release the medication directly into the surgical bed over several weeks. This aims to fight localized post-operative infections or promote advanced tissue regeneration without the systemic side effects of oral or IV drugs.

Disclaimer

The research discussed regarding the use of the fibrin matrix as a localized drug delivery system for targeted antibiotics, chemotherapy agents, or stem cells to promote advanced tissue regeneration is currently in the preclinical or early investigational phase and is not yet applicable to practical or professional clinical scenarios.

Patient Management and Practical Recommendations

(Note: Because this medication is administered exclusively by surgeons in an operating room, these protocols apply to the surgical and anesthesia teams).

• Preparation & Handling: Liquid vials must be thawed from a frozen state or warmed strictly according to the manufacturer’s temperature guidelines to ensure the delicate proteins do not denature prior to use.
• Equipment Verification: If using a pressurized spray applicator, the surgical team must strictly adhere to the manufacturer’s recommended distance (usually 10 to 15 cm from the tissue) and pressure limits to prevent gas embolisms.
• Allergy Verification: The anesthesia team must verify if the patient has a known severe allergy to human blood products or specific animal proteins (e.g., bovine or equine), depending on the exact brand of hemostatic being utilized.

Legal Disclaimer

For informational purposes only; this document does not replace professional medical advice from a qualified healthcare provider. This content is not intended to be a substitute for professional medical diagnosis, treatment protocols, or clinical judgment. Always seek the advice of your physician or surgeon with any questions you may have regarding surgical procedures, bleeding risks, or medical interventions.